SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-020747
Filing Date
2021-01-28
Accepted
2021-01-28 16:01:53
Documents
13
Period of Report
2021-01-27
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d117561d8k.htm   iXBRL 8-K 25545
2 EX-3.1 d117561dex31.htm EX-3.1 108963
  Complete submission text file 0001193125-21-020747.txt   296755

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rgen-20210127.xsd EX-101.SCH 3082
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20210127_lab.xml EX-101.LAB 19659
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20210127_pre.xml EX-101.PRE 12323
6 EXTRACTED XBRL INSTANCE DOCUMENT d117561d8k_htm.xml XML 3720
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14656 | Film No.: 21564918
SIC: 2836 Biological Products, (No Diagnostic Substances)